Skip to main content

Mirikizumab

Generic name: mirikizumab [ MIR-i-KIZ-ue-mab ]
Brand name: Omvoh
Dosage forms: intravenous solution (mrkz 20 mg/mL), subcutaneous solution (mrkz 100 mg/mL)
Drug class: Interleukin inhibitors

Medically reviewed by Drugs.com on Jan 16, 2024. Written by Cerner Multum.

What is mirikizumab?

Mirikizumab is used in adults to treat moderate to severe ulcerative colitis.

Mirikizumab may also be used for purposes not listed in this medication guide.

Mirikizumab side effects

Get emergency medical help if you have signs of an allergic reaction: hives, difficult breathing, swelling of your face, lips, tongue, or throat.

Some side effects may occur during the injection. Tell your medical caregiver if you feel dizzy, nauseated, light-headed, itchy, sweaty, or have a headache, chest tightness, back pain, trouble breathing, or swelling in your face.

You may get infections more easily, even serious or fatal infections. Call your doctor right away if you have signs of infection such as:

Mirikizumab may cause serious side effects. Call your doctor at once if you have:

Your treatments may be delayed or permanently discontinued if you have certain side effects.

Common side effects of mirikizumab may include:

This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.

Warnings

You may get infections more easily, even serious or fatal infections. Call your doctor if you have flu symptoms, cough, night sweats, skin sores, painful urination, neck stiffness, confusion, or vision problems.

Before taking this medicine

You should not use mirikizumab if you are allergic to it.

Before you start using mirikizumab, tell your doctor if you have any signs of infection such as fever, chills, cough, body aches, tiredness, open sores or skin wounds, diarrhea, stomach pain, weight loss, painful urination, or coughing up blood.

Tell your doctor if you have or have ever had:

Make sure you are current on all vaccines before you start using mirikizumab.

If you are pregnant, your name may be listed on a pregnancy registry to track the effects of mirikizumab on the baby.

Tell your doctor if you are pregnant or breastfeeding.

How should I use mirikizumab?

Follow all directions on your prescription label and read all medication guides or instruction sheets. Use the medicine exactly as directed.

Before you use mirikizumab, your doctor may test you for tuberculosis or other infections.

For the first 3 doses, mirikizumab is injected into a vein by a healthcare provider every 4 weeks.

Later doses are then injected under the skin every 4 weeks. A healthcare provider may give you this injection or teach you how to properly use mirikizumab by yourself.

Your dose should be given as 2 injections under the skin to receive the full dose. Your healthcare provider will show you where to inject mirikizumab. Do not inject into the same place two times in a row. Do not give an injection into skin that is hard, red, bruised, or tender.

Do not shake the injection pen.

Ask your doctor or pharmacist if you don't understand how to use an injection pen.

Prepare an injection pen only when you are ready to give it. Call your pharmacist if the medicine looks cloudy, has changed colors or has particles in it.

Each injection pen is for one use only. Throw away after one use, even if there is still medicine left inside. Place them in a puncture-proof "sharps" container and dispose of it following state or local laws. Keep out of the reach of children and pets.

You may get infections more easily, even serious or fatal infections. You will need frequent medical tests.

You will need frequent blood tests to check your liver function.

Store the medicine in the original container in the refrigerator. Protect from light and do not freeze.

Take the medicine out of the refrigerator and let it reach room temperature for 30 minutes before using. Do not warm the medicine with hot water, sunlight, or a microwave.

Mirikizumab may also be stored in the original container at room temperature away from moisture, heat and light. Do not return the medicine to the refrigerator. Throw the medicine away after 2 weeks if stored at room temperature.

Mirikizumab dosing information

Usual Adult Dose for Ulcerative Colitis:

Induction dose: 300 mg IV over at least 30 minutes at weeks 0, 4, and 8
Maintenance dose: 200 mg subcutaneously at week 12, and every 4 weeks thereafter

Comments:
-The 200 mg subcutaneous dose should be administered as 2 consecutive 100 mg prefilled injections.

Use: For the treatment of moderately and severely active ulcerative colitis

What happens if I miss a dose?

Use the medicine as soon as you remember, and then go back to your regular schedule. Do not use two doses at one time.

What happens if I overdose?

Seek emergency medical attention or call the Poison Help line at 1-800-222-1222.

What should I avoid while using mirikizumab?

Never share an injection pen even if you changed the needle. Sharing these devices can pass infections from person to person.

Avoid receiving a "live" vaccine while using mirikizumab, or you could develop a serious infection. Live vaccines include measles, mumps, rubella (MMR), rotavirus, typhoid, yellow fever, varicella (chickenpox), and zoster (shingles).

What other drugs will affect mirikizumab?

Other drugs may affect mirikizumab, including prescription and over-the-counter medicines, vitamins, and herbal products. Tell your doctor about all other medicines you use.

Further information

Remember, keep this and all other medicines out of the reach of children, never share your medicines with others, and use this medication only for the indication prescribed.

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.